Professional Documents
Culture Documents
Chemical Methods
•Chemosterilizers- chemical agents used for •Aldehydes
sterilization •Halogens
*disinfectants are regulated by US Environmental •Chlorine and chlorine compounds
Protection Agency (EPA) •Detergent; quaternary ammonium compounds
*sterilants are regulated by US Food and Drug •Phenolics
Administration (FDA) when they are able to be used to •Heavy metals
sterilize devices that will come into contact w/ patients •Gases
•Exfoliative toxin
-also known as epidermolytic toxin
-causes epidermal layer of the skin to slough off and is
known to cause staphylococcal SSS, sometimes referred
to as Ritter disease
-this toxin has also been implicated in bullous
impetigo
•Other infections
Staphylococcal pneumonia
•Toxin Shock Syndrome -has been known to occur secondary to influenza virus
-multisystem disease characterized by sudden onset of infection
fever, chills, vomiting, diarrhea, muscle aches, and rash, -has high mortality rate especially on infants and
which can quickly progress to hypotension and shock immunocompromised individuals
-rash is found predominantly on trunk but can spread -develops lower respiratory tract infection or
over the entire body complication of bacteremia
1. non-menstruating TSS- has been associated with -characterized by multiple abscesses and focal lesions in
nearly any staphylococcal infection, many cases have pulmonary parenchyma
been seen with postsurgical infections and secondary to -infants and immunocompromised individuals such as
influenza virus infections elderly patients and patient receiving chemotherapy or
2. menstruating-associated TSS immunosuppressant are mostly infected
*Staphylococcal TSS generally results from a localized
infection by S. aureus; only the toxin TSST-1 is systemic
•Food Poisoning
-occurs when food becomes contaminated with
enterotoxins-producing strains of S. aureus by improper
handling and is then improperly stored
-S. aureus enterotoxins, most commonly A (78%), D
(38%), and B (10%), have been associated with
gastrointestinal disturbances
Staphylococcus epidermidis Cultural Characteristics
-common cause of health care-acquired UTIs -Staphylococci produce round, smooth, white, creamy
-prosthetic valve endocarditis is most commonly caused colonies on SBA after 18-24 hours of incubation at 35-
by S. epidermidis 37C.
-infections associated with use of implants, such as -S. aureus can produce hemolytic zones around the
indwelling catheters and prosthetic devices, are often colonies and may rarely exhibit pigment production
caused by isolates shown to produce biofilm (yellow) with extended incubation
*Biofilm production is a key component in bacterial -S. epidermidis colonies are usually small to medium-
pathogenesis and is a complex interaction between host, sized, nonhemolytic, gray-to-white colonies. Some can
indwelling device, and bacteria be weakly hemolytic.
Pathogenesis and Spectrum of Disease SBA- enriched differential medium; differentiates diff
-S. aureus and S. epidermidis produce a polysaccharide types of hemolysis
capsule that inhibits phagocytosis. The capsule, which is
produced in various amounts by individual clinical
isolates, may appear as slime layer or biofilm and allows
organisms to adhere to inorganic surfaces and impairs
or inhibits the penetration of antibiotics
Staphylococcus saprophyticus
-has been associated with UTIs in young women Beta hemolysis- there is complete clearing or halo
-this species adheres more effectively to the epithelial around it (s. aureus is yellowish)
cells lining the urogenital tract than other CoNS
(coagulase negative staphylococci) Identification Methods
-when present in urine cultures, S. saprophyticus may •Staphylococci ferment glucose, whereas micrococci fail
be found in low numbers (<10,000 colony forming to produce acid under anaerobic conditions.
units/ml) and still be considered significant (>100,000) •Staphylococcus aureus
Streptococcus
General Characteristics
-gram-positive, nonmotile, non-sporeforming, catalase-
negative cocci that occur in pairs or chains
-appear more elongated than spherical Streptococcus pyogenes (Group A Streptococci)
-most are facultative anaerobes, some are aerotolerant Characteristics
anaerobes -gram-positive cocci in chain
-most require enriched media (blood agar) -nonmotile, facultative anaerobes
-colonies are usually small and transparent -capsule
-beta-hemolysis on BA
Hemolysis -catalase (-)
-the streptococci and similar organisms can produce -bacitracin sensitivity test- presumptive test for
numerous exotoxins that damage intact red blood cells identification of Group A streptococci
(RBC)
Virulence Factors
•M protein- antiphagocytic; major virulence factor
limiting phagocytosis disturbing the function of
complement and being responsible for adhesion
•Lipoteichoic acid- mediates adherence to epithelial
cells of mouth and skin
•Capsule- prevents phagocytosis by neutrophils or
macrophages, mask its antigen and remain
unrecognized by its host
•Streptococcal pyrogenic exotoxins- responsible for
rash seen in scarlet fever
Cell Wall Structure •Streptolysin O- O2 labile, highly immunogenic; lyses
-streptococci possess a typical gram-positive cell wall leukocytes, platelets, RBCs
consisting of peptidoglycan and teichoic acid •Streprolysin S- O2 stable, non-immunogenic, lyses
-most streptococci, except for many of the viridians •Streptokinase- causes plasminogen to convert into a
group, have a group or common C carbohydrate protease (plasmin), which lyses the fibrin clot
(polysaccharide), which can be used to classify an •DNAse- reduces viscosity of abscess material and
isolate serologically facilitates spread of organisms
-Rebecca Lancefield was able to divide the streptococci •Hyaluronidase (spreading factor)- an enzyme that
into serologic groups, designated by letters. Organisms solubilises the ground substance of mammalian
in group A possess the same antigenic C carbohydrate, connective tissue
organisms in group B have the same C carbohydrate,
and so on. Clinical Infections
Streptococcus pyogenes colonizes the throat and skin
Clinically Significant Streptococci in humans making these primary sources of
-clinically isolated streptococci have historically been transmission
separated into B-hemolytic streptococci or pyogenic
(pus-forming) streptococci and species that are non-B-
hemolytic (nonpyogenic)
-pyogenic streptococci isolated frequently from humans
include Streptococcus pyogenes, Streptococcus
•Bacterial Pharyngitis •Post-streptococcal sequelae
-Group A streptococci is the major cause of bacterial -non-infectious disease, an immune disease
pharyngitis -occurs 2-4 weeks after a streptococcal infection of the
-Strep throat is most often seen in children between 5 throat and skin
and 15 yrs of age -mechanism of cross-reactivity: certain strains of Group
-after an incubation period of 1-4 dyas, an abrupt onset A streptococci share a similar antigenic structure with
of illness ensues, with sore throat, malaise, fever and heart tissue and glomeruli--- cross-reacting
headache antibodies--- damage to these organs
o Acute rheumatic heart fever--- damage of heart
-transmission: droplet spray and close contact valves--- rheumatic heart disease
o Acute glomerulonephritis--- damage to the
glomeruli--- impairment of kidney function
Laboratory Diagnosis
•Microscopy- gram stained smear
•Culture- BA (beta-hemolytic)
•Bacitracin sensitivity test
•ASO (Anti-streptolysin O) detection
•Scarlet Fever
Prevention and Control
-caused by streptococcal pyrogenic exotoxins
•Cleanliness and hygiene
-initial symptoms of pharyngitis
•Strict aseptic technique
-followed 1-2 days after with a diffuse erythematous
• Prompt treatment to prevent post-streptococcal
rash--- desquamation
complications
*GAS (Group A Streptococci) are susceptible to
penicillin. For patients allergic to penicillin,
erythromycin can be used. For patients who have a
history of rheumatic fever, prophylactic doses of
penicillin are given to prevent recurrent infections.
Virulence Factors
-Capsule
-Hemolysin
-Protease
-Neuraminidase
-Hyaluroidase
General Characteristics
•Aerobic, nonmotile, non-spore forming, gram-
negative diplococci
•Neisseria elongata, Neisseria weaveri, and Neisseria Neisseria meningitidis
bacilliformis are known exceptions and are rod Neisseria gonorrhoeae
shaped Characteristics
•Cytochrome oxidase (+), catalase (+) except for N. •Gram (-) coffee bean-shaped diplococci
elongata subsp. nitroreducens and N. bacilliformis, •Usually intracellular
which are catalase negative •Facultative anaerobes, growth enhanced in
•Capnophilic meaning they require carbon dioxide increased CO2 concentration
(CO2) for growth and have optimal growth in a •Fastidious organisms with complex nutritional
humid atmosphere requirement
•Can grow anaerobically if alternative electron •Grow in CA (chocolate agar), not in NA (nutrient
acceptors are available agar)
•Natural habitat: mucous membranes of the •Selective (enriched) medium: Thayer Martin
respiratory and urogenital tracts (modified chocolate agar by adding antibiotics)
•Require IRON for growth
•Colonies: small, translucent, raised, moist, grayish
white, usually mucoid with entire to lobate margins
•Produce catalase and cytochrome oxidase
•Very susceptible to adverse environmental and
susceptible to disinfectants
•Exclusive human pathogen
Epidemiology
•N. meningitidis can be found on the mucosal
surfaces of the nasopharynx and oropharynx in 30%
of the population
•The organism is transmitted by close contact with •Meningitis
respiratory droplet secretions from a carrier to a new - frontal headache, stiff neck (nuchal rigidity),
host confusion and photophobia
•Of the 12 meningococcal encapsulated serogroups,
A, B, C, Y, and W-135 account for most cases of •Other complications include arthritis, pericarditis,
diseases in the world and pneumonia, conjunctivitis and urethritis
Virulence Factors
•Capsule
•Pili (fimbriae)
•Endotoxin (LPS)- diffuse vascular damage and DIC
(Disseminated Intravascular Coagulation-
inappropriate clotting of blood)
•Protease
•Cell membrane proteins
Transmission: droplet spray
Laboratory Diagnosis
Specimen Collection and Transport
Specimens: cerebrospinal fluid (CSF), blood,
nasopharyngeal swabs and aspirates, joint fluids, and
less commonly sputum and urogenital sites.
Collection and transport should be performed as
specified by the laboratory for the various specimen
type.
•Presumptive diagnosis
Microscopy
Culture
Oxidase test
•Meningococcemia
- fulminant septicemia (life-threatening)
- spread to skin--- petechial skin lesions--- purpura
- tachycardia, hypotension, and thrombosis can
develop during bacteremia
- patients may develop DIC, septic shock, or
hemorrhage in the adrenal glands (Waterhouse-
Friderichsen syndrome)
Treatment Virulence Factors
•The drug of choice for treatment of confirmed N. •Pili (fimbriae)
meningitidis meningitis is penicillin; •Endotoxin (LPS)
meningococcemia is best treated with third- •Protease
generation cephalosporins •Cell membrane proteins
•Chemoprophylaxis with rifampin or ciprofloxacin is •Beta-lactamase
recommended for close contacts Transmission: sexual contact
•Azithromycin can be used in areas where
ciprofloxacin resistance is a problem Clinical Infections
•Chemoprophylaxis is not recommended for •Gonorrhea
asymptomatic carriers IP: 2-7 days (IP- Incubation Period)
Men:
Vaccine -infections are primarily restricted to the urethra
•The quadrivalent vaccine Menactra is a -acute urethritis
polysaccharide-protein conjugated vaccine with -earliest manifestation is dysuria (painful urination,
antigens to serogroups A, C, Y, and W-135 burning sensation)--- followed by the purulent
•The Advisory Committee on Immunization Practices urethral discharge
recommends routine vaccination be administered to -95% of infected male are symptomatic
individuals at age 11 to 12 years with a booster dose -complications: prostatitis and epididymitis,
at age 16 years periurethral abscess, urethral strictures and painful
•Individuals who receives their first dose at age 16 erection
years or older do not need a booster dose unless they
are at a high risk of invasive meningococcal disease Women:
-primary site is the cervix and urethra
Prevention and Control -many are asymptomatic (carriers or reservoirs)
•Identification and treatment of carriers -asymptomatic cases in women may lead to
(nasopharynx) complication: salpingitis, pelvic inflammatory disease
•Antibiotic prophylaxis (PID) which may cause sterility, ectopic pregnancy,
•Polyvalent vaccines or perihepatitis (Fitz-Hugh-Curtis syndrome)
-symptoms: dysuria, cervical discharge, and lower
Neisseria gonorrhoeae (gonococcus) abdominal pain
•Humans are the only natural host for N.
gonorrhoeae, the agent of gonorrhea Children:
•Gonococcal infections are primarily acquired by Ophthalmia neonatorum- gonococcal eye infection in
sexual contact and occur primarily in the urethra, newborn
endocervis, anal canal, pharynx, and conjunctiva -antimicrobial eyedrops,
generally erythromycin
Gonococcal conjunctivitis- sexually abused children
Epidemiology
•N. gonorrhoeae infections are most commonly
transmitted by sexual contact
•The primary reservoir is the asymptomatic carrier
•Gonorrhea is second to Chlamydia trachomatis in
the number of confirmed sexually transmitted
bacterial infections in the United States
•Sexually active teens and young adults have the
highest rates of infection
•Overall, highest rates are recorded in urban areas
where individuals are more likely to have multiple
partners and unprotected sexual intercourse
Laboratory Diagnosis
Specimen Collection and Transport
Specimens collected for the recovery of N.
gonorrhoeae may come from genital sources or from
other sites, such as the rectum, pharynx, and joint
fluid.
The specimen of choice for genital infections in men
is the urethra and in women is the endocervix.
Best clinical specimens from infected males and
females: urine, urethral/vaginal discharge, synovial
fluid, etc.
•Presumptive Diagnosis:
Microscopy
Culture
Oxidase test
Moraxella catarrhalis
•Normal inhabitant of the upper respiratory tract
•May occasionally cause meningitis and OM (otitis
media) but generally non-pathogenic
•Can grow on NA (nutrient agar)
•Oxidase, catalase (+)
•CHO fermentation test = (-) for G, M, L, S
Clinical Infections
M. catarrhalis is an opportunistic pathogen and is
recognized as a cause of:
-upper respiratory tract infection
-lower respiratory infections (adults with chronic
obstructive pulmonary disease)
-acute otitis media, sinusitis
-rare infections: endocarditis, meningitis, and
bacterial tracheitis
Laboratory Diagnosis
Specimen Collection and Identification
-Typical specimens: collected from middle ear
effusion, nasopharynx, sinus aspirates, sputum
aspirates, or bronchial aspirates
-Organism grows on both SBA and CHOC agar
-Most strains of M. catarrhalis can grow well at 28C
-M. catarrhalis is usually inhibited on gonococcal
selective agars by collistin, but some strains resistant
to this antimicrobial may grow
-The organism is asaccharolytic, and it may be
differentiated from Neisseria spp. by positive DNase
and butyrate esterase reactions